EUVIMEDEUVIMED entdecken
BeobachtungsstudieKohortenstudie

Chemical neurolysis of the genicular nerves for chronic refractory knee pain: an observational cohort study

Wassi Shaikh, Scott Miller, Zachary L McCormick iD, Prachi Milan Patel, Masaru Teramoto, David R Walega

Pain Medicine · 2023

DOI: 10.1093/pm/pnad022 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pain Medicine, 2023. Verfasst von Wassi Shaikh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Northwestern Feinberg School of Medicine, Chicago, IL 60611, United States. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Nerve Block, Chronic Pain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Evaluate outcomes of genicular nerve chemical neurolysis (GChN) in a real-world population with chronic knee pain.

Design

Restrospective, observational cohort study.

Setting

Tertiary academic medical center. Subjects Consecutive patients who had undergone GChN ≥3 months prior.

Methods

Standardized surveys were collected by telephone and included the numerical rating scale, opioid analgesic use, and Patient Global Impression of Change. Age, sex, body mass index, duration of pain, history of arthroplasty, lack of effect from previous radiofrequency ablation, percentage relief from a prognostic block, and volume of phenol used at each injection site were extracted from charts. Descriptive statistics were calculated, and logistic regression analyses were performed to identify factors influencing treatment outcome.

Results

At the time of follow-up after GChN (mean ± SD: 9.9 ± 6.1 months), 43.5% (95% CI = 33.5–54.1) of participants reported ≥50% sustained pain reduction. On the Patient Global Impression of Change assessment, 45.9% (95% CI = 35.5–56.7) of participants reported themselves to be “very much improved” or “much improved.” Of 40 participants taking opioids at baseline, 11 (27.5%; 95% CI = 14.6–43.9) ceased use. Of participants with a native knee treated, 46.3% reported ≥50% pain reduction, whereas of participants with an arthroplasty in the treated knee, 33.3% reported this threshold of pain reduction (P = .326). Logistic regression analyses did not reveal associations between treatment success and any of the factors that we evaluated.

Conclusions

GChN could provide a robust and durable treatment effect in a subset of individuals with chronic knee pain with complicating factors traditionally associated with poor treatment outcomes, such as those with pain refractory to radiofrequency ablation or those who have undergone arthroplasty.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoarthritis, KneeNerve BlockChronic PainHumansPain ManagementKnee JointTreatment OutcomeCohort Studies

Stichwörter der Autor:innen

kneeosteoarthritisphenoltotal knee replacement

Autor:innen und Institutionen

  • Department of Anesthesiology, Northwestern Feinberg School of Medicine, Chicago, IL 60611, United States.
  • Department of Physical Medicine and Rehabilitation, University of Utah School of Medicine, Salt Lake City, UT 84108, United States.

ORCID-Profile: Zachary L McCormick

Zitieren

APA

Shaikh, W., Miller, S., McCormick, Z. L., Patel, P. M., Teramoto, M., & Walega, D. R. (2023). Chemical neurolysis of the genicular nerves for chronic refractory knee pain: an observational cohort study. Pain Medicine. https://doi.org/10.1093/pm/pnad022

Vancouver

Shaikh W, Miller S, McCormick ZL, Patel PM, Teramoto M, Walega DR. Chemical neurolysis of the genicular nerves for chronic refractory knee pain: an observational cohort study. Pain Medicine. 2023. doi:10.1093/pm/pnad022

BibTeX
@article{Shaikh2023,
  author = {Shaikh, Wassi and Miller, Scott and McCormick, Zachary L and Patel, Prachi Milan and Teramoto, Masaru and Walega, David R},
  title = {Chemical neurolysis of the genicular nerves for chronic refractory knee pain: an observational cohort study},
  journal = {Pain Medicine},
  year = {2023},
  doi = {10.1093/pm/pnad022}
}
Kostenlos starten →